Systemic sclerosis: Brain abnormalities revealed by conventional magnetic resonance imaging and magnetization transfer imaging

Arthritis and Rheumatism

Volumn 54, Issue 4, 2006, Pages 1350-1352

  Argyropoulou, Maria I ^a   Tsifetaki, Niki ^a   Zikou, Anastasia K ^a   Xydis, Vassilios ^a   Venestanopoulou, Aliki I ^a   Margariti, Persefoni ^a   Drosos, Alexandros A ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BRAIN ISCHEMIA; CEREBROVASCULAR DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEAFFERENTATION; DEMYELINATION; FEMALE; FLUID ATTENUATED INVERSION RECOVERY; FRONTAL CORTEX; HUMAN; MALE; MICROANGIOPATHY; NERVE FIBER DEGENERATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAYNAUD PHENOMENON; SYSTEMIC SCLEROSIS; TECHNIQUE; WHITE MATTER; WHITE MATTER HYPERINTENSITY;

BRAIN DISEASES; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; SCLERODERMA, SYSTEMIC;

EID: 33646378130     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.21738     Document Type: Article

References (16)

1. Blann AD, Illingworth K, Jayson MI. Mechanisms of endothelial cell damage in systemic sclerosis and Raynaud's phenomenon. J Rheumatol 1993;20:1325-30.
2. Gordon RM, Silverstein A. Neurologic manifestations in progressive systemic sclerosis. Arch Neurol 1970;22:126-34.
3. Héron E, Hernigou A, Chatellier G, Fornes P, Emmerich J, Fiessinger JN. Intracerebral calcification in systemic sclerosis. Stroke 1999;30:2183-5.
4. Gutolo M, Nobili F, Sulli A, Pizzorni C, Briata M, Faelli F, et al. Evidence of cerebral hypoperfusion in scleroderma patients. Rheumatology (Oxford) 2000;39:1366-73.
5. Sardanelli F, Iozzelli A, Cotticelli B, Losacco C, Cutolo M, Sulli A, et al. White matter hyperintensities on brain magnetic resonance in systemic sclerosis. Ann Rheum Dis 2005;64:777-9.
6. Xydis V, Astrakas L, Zikou A, Pantou K, Andronikou S, Argyropoulou MI. Magnetization transfer ratio in the brain of preterm subjects: age-related changes during the first 2 years of life. Eur Radiol 2006;16:215-20.
7. Steens SC, Admiraal-Behloul F, Bosma GP, Steup-Beekman GM, Olofsen H, le Cessie S, et al. Selective gray matter damage in neuropsychiatric lupus: a magnetization transfer imaging study. Arthritis Rheum 2004;50:2877-81.
8. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
9. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15:202-5.
10. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. (DSM IV). Washington (DC): American Psychiatric Association; 1994.
11. Schmidt R, Enzinger C, Ropele S, Schmidt H, Fazekas F, the Austrian Stroke Prevention Study. Progression of cerebral white matter lesions: 6-year results of the Austrian Stroke Prevention Study. Lancet 2003;361:2046-8.
12. Herrick AL. Pathogenesis of Raynaud's phenomenon. Rheumatology (Oxford) 2005;44:587-96.
13. Takano T, Kimura K, Nakamura M, Fukunaga R, Kusunoki M, Etani H, et al. Effect of small deep hemispheric infarction on the ipsilateral cortical blood flow in man. Stroke 1985;16:64-9.
14. Tullberg M, Fletcher E, DeCarli C, Mungas D, Reed BR, Harvey DJ, et al. White matter lesions impair frontal lobe function regardless of their location. Neurology 2004;63:246-53.
15. Tien RD, Ashdown BC. Crossed cerebellar diaschisis and crossed cerebellar atrophy: correlation of MR findings, clinical symptoms, and supratentorial diseases in 26 patients. AJR Am J Roentgenol 1992;158:1155-9.
16. Wakita H, Tomimoto H, Akiguchi I, Matsuo A, Lin JX, Ihara M, et al. Axonal damage and demyelination in the white matter after chronic cerebral hypoperfusion in the rat. Brain Res 2002;924:63-70.